Dr Marwa Rahimi
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
17 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Correction: Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting
DOI: 10.1039/d6ra90008a2026
Journal article
Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting
DOI: 10.1039/d5ra08789a2025
Conference Proceedings
Radiolabelled peptides targeting CXCR4 for cancer imaging and treatment
DOI: 10.1016/j.nucmedbio.2025.1094192025
Conference Proceedings
Dual Function, Singular Impact: Successes of a Novel Class of Theranostic Gastramide (GA) Peptides Targeting Cholecystokinin-2 Receptor
DOI: 10.1016/j.nucmedbio.2025.1095302024
Journal article
Precision peptide theranostics: developing N- to C-terminus optimized theranostics targeting cholecystokinin-2 receptor
DOI: 10.7150/thno.897012023
Conference Proceedings
The Next Generation of Tumour Homing Peptides: Foldamers at the Forefront of Precise Cancer Theranostics
DOI: 10.1016/j.nucmedbio.2023.1087942023
Conference Proceedings
First-In-Class Diagnostics Targeting Neuropeptide Y1 Receptor (Y1R): Enabling Molecular Imaging of Metastatic Breast Cancer
DOI: 10.1016/j.nucmedbio.2023.108792
RECENT SCHOLARLY WORKS
2023
Journal article
Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin-2 Receptor Positive Cancers
DOI: 10.1021/acs.jmedchem.3c003772021
Conference Proceedings
Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate
DOI: 10.1016/s0969-8051(21)00445-52021
Journal article
Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development.
DOI: 10.1002/chem.201905385